Oropharyngeal Neoplasms - Therapy
Research News and Information

Sunday, November 22, 2009

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

30 Jul 2009 OBJECTIVES/HYPOTHESIS: The human papillomavirus (HPV) has been identified as a causative factor in 20% to 25% of all head and neck squamous cell carcinomas (HNSCC). Ongoing research suggests that the presence of HPV DNA in HNSCC predicts a positive ... Read more...

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.

27 Jul 2009 The burden of squamous cell carcinoma of the head and neck (SCCHN) is greater for blacks than for whites, especially in oropharyngeal cases. We previously showed retrospectively that disease-free survival was significantly greater in white than in ... Read more...

Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer.

29 Jun 2009 OBJECTIVE: Speech impairment often occurs in patients after treatment for head and neck cancer. New treatment modalities such as surgical reconstruction or (chemo)radiation techniques aim at sparing anatomical structures that are correlated with ... Read more...

Latest indexed articles for 'Oropharyngeal Neoplasms - Therapy'

These are the very latest articles for this heading:

• Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. 30 Jul 2009
• Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. 27 Jul 2009
• Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer. 29 Jun 2009
• Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. 27 May 2009
• Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. 29 Apr 2009
• Oropharyngeal cancer: current understanding and management. 30 Mar 2009
• Screening for dysfunction to promote multidisciplinary intervention by using the University of Washington Quality of Life Questionnaire. 30 Mar 2009
• Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. 27 Feb 2009
• Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. 22 Feb 2009
• Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma. 30 Jan 2009
• Multimodal treatment for head and neck cancer. 30 Jan 2009
• HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. 30 Jan 2009
• Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. 30 Jan 2009
• Contemporary management of oropharyngeal cancer: anatomy and physiology of the oropharynx. 30 Jan 2009
• Foreword. This issue of Current Problems in Surgery with Drs. Duvvuri and Myers. 30 Jan 2009
• Speech and swallowing impairment after treatment for oral and oropharyngeal cancer. 29 Nov 2008
• Long-term survivor model with bivariate random effects: applications to bone marrow transplant and carcinoma study data. 27 Nov 2008
• Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. 25 Oct 2008
• Cancer of the oro- and hypopharynx - when to expect recurrences? 30 Jul 2008
• Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray. 30 May 2008

See a longer list of these articles.

Technical information about 'Oropharyngeal Neoplasms'

Definition: Tumors or cancer of the OROPHARYNX.

Descriptor UI: D009959

Alternative terms: Oropharyngeal Neoplasms; Neoplasm, Oropharyngeal; Oropharyngeal Neoplasm; Oropharynx Neoplasms; Neoplasm, Oropharynx; Neoplasms, Oropharynx; Oropharynx Neoplasm; Neoplasms, Oropharyngeal; Cancer of Oropharnyx; Oropharnyx Cancer; Oropharnyx Cancers; Oropharyngeal Cancer; Cancer, Oropharyngeal; Cancers, Oropharyngeal; Oropharyngeal Cancers; Oropharynx Cancer; Cancer, Oropharynx; Cancers, Oropharynx; Oropharynx Cancers; Cancer of the Oropharynx;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.443.665.710.684; C07.550.745.671; C09.647.710.685; C09.775.549.685;

History Note: 91(85); was see under PHARYNGEAL NEOPLASMS 1985-90

Technical Notes: coord IM with histol type of neopl (IM)